Demonstrações financeiras detalhadas de Intellia Therapeutics, Inc. (NTLA): demonstração de resultados, balanço patrimonial e fluxo de caixa. Acompanhe a evolução de margens, dívida, liquidez e rentabilidade ano a ano com até 20 anos de histórico.
Resumo da Análise
Intellia Therapeutics, Inc. registou receitas de $67.7M no último exercício, com um CAGR de 5 anos de 3.1%.
Margens dos últimos 12 meses: margem bruta -46.5%, margem operacional -7.1%, margem líquida -6.7%.
Ao preço atual de $11.49, NTLA apresenta lucros negativos (P/L não significativo) e um ROE de -57.79%. A capitalização de mercado é de $1.6B.
Demonstração de Resultados (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Receita | $16.5M | $26.1M | $30.4M | $43.1M | $58.0M | $33.1M | $52.1M | $36.3M | $57.9M | $67.7M |
| Custo da Receita | $31.8M | $67.6M | $89.1M | $108.4M | $150.4M | $6.9M | $7.6M | $9.0M | $10.3M | $15.9M |
| Lucro Bruto | -$15.4M | -$41.5M | -$58.7M | -$65.3M | -$92.4M | $26.2M | $44.5M | $27.3M | $47.6M | $51.7M |
| P&D | $31.8M | $67.6M | $89.1M | $108.4M | $150.4M | $229.8M | $420.0M | $435.1M | $466.3M | $388.9M |
| Despesas Gerais e Administrativas | $16.8M | $28.0M | $32.2M | $41.1M | $44.2M | $71.1M | $90.3M | $116.5M | $125.8M | $119.8M |
| Despesas Operacionais | $48.6M | $95.7M | $121.3M | $41.1M | $44.2M | $294.0M | $502.7M | $542.6M | $581.9M | $492.7M |
| Lucro Operacional | -$32.2M | -$69.6M | -$90.9M | -$106.4M | -$136.6M | -$267.9M | -$458.2M | -$515.3M | -$534.3M | -$441.0M |
| EBITDA | -$31.1M | -$66.6M | -$86.4M | -$100.8M | -$130.3M | -$261.0M | -$466.6M | -$472.2M | -$508.7M | -$396.8M |
| Despesas com Juros | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Lucro Antes de Impostos | -$31.6M | -$67.5M | -$85.3M | -$99.5M | -$134.2M | -$267.9M | -$474.2M | -$481.2M | -$519.0M | -$412.7M |
| Imposto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Lucro Líquido | -$31.6M | -$67.5M | -$85.3M | -$99.5M | -$134.2M | -$267.9M | -$474.2M | -$481.2M | -$519.0M | -$412.7M |
| LPA | $-0.91 | $-1.88 | $-1.98 | $-1.96 | $-2.40 | $-3.78 | $-6.16 | $-5.42 | $-5.25 | $-3.81 |
| LPA Diluído | $-0.91 | $-1.88 | $-1.98 | $-1.96 | $-2.40 | $-3.78 | $-6.16 | $-5.42 | $-5.25 | $-3.81 |
| Ações em Circulação (Diluídas) | $34.6M | $36.0M | $43.1M | $47.2M | $56.0M | $70.9M | $77.0M | $88.8M | $98.8M | $108.4M |
Demonstração de Resultados (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Receita | $13.8M | $23.0M | $15.0M | $7.7M |
| Lucro Bruto | -$65.2M | $17.0M | $12.8M | $7.7M |
| Lucro Operacional | -$111.5M | -$98.7M | -$100.5M | -$112.8M |
| EBITDA | -$96.4M | -$95.4M | -$94.0M | -$104.5M |
| Lucro Líquido | -$101.3M | -$95.8M | -$96.2M | -$106.6M |
| LPA | $-0.92 | $-0.83 | $-0.81 | $-0.80 |
| LPA Diluído | $-0.92 | $-0.83 | $-0.81 | $-0.80 |
Balanço (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caixa e Equivalentes | $273.1M | $340.7M | $58.9M | $57.2M | $160.0M | $123.4M | $523.5M | $226.7M | $189.2M | $155.5M |
| Investimentos de Curto Prazo | 0 | 0 | $255.2M | $222.5M | $437.4M | $625.3M | $669.1M | $685.5M | $412.3M | $294.4M |
| Contas a Receber | $6.5M | $10.5M | $7.5M | $4.6M | $2.1M | $2.0M | $3.8M | $36.5M | $8.5M | $9.5M |
| Estoque | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ativos Circulantes | $281.3M | $354.8M | $325.0M | $289.5M | $616.5M | $769.3M | $1.22B | $998.3M | $639.9M | $527.7M |
| Imobilizado | $10.6M | $15.3M | $17.1M | $37.1M | $55.1M | $100.1M | $161.0M | $148.1M | $246.7M | $123.6M |
| Ágio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ativos Intangíveis | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ativos Totais | $299.0M | $376.2M | $347.3M | $334.3M | $676.3M | $1.29B | $1.52B | $1.30B | $1.19B | $842.1M |
| Contas a Pagar | $4.7M | $2.2M | $2.7M | $3.9M | $10.5M | $9.7M | $5.2M | $7.5M | $14.6M | $20.3M |
| Dívida de Curto Prazo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passivos Circulantes | $30.7M | $31.4M | $40.6M | $35.6M | $64.3M | $125.8M | $126.6M | $115.2M | $110.9M | $103.9M |
| Dívida de Longo Prazo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $66.8M |
| Passivos Totais | $89.1M | $75.6M | $69.4M | $64.4M | $149.2M | $254.2M | $284.5M | $250.8M | $319.1M | $170.7M |
| Reservas | -$53.6M | -$121.1M | -$201.0M | -$300.9M | -$435.1M | -$703.0M | -$1.18B | -$1.66B | -$2.18B | -$2.59B |
| Patrimônio Líquido | $209.8M | $300.6M | $277.9M | $269.9M | $527.1M | $1.04B | $1.24B | $1.05B | $872.0M | $671.4M |
| Dívida Total | 0 | 0 | 0 | $18.4M | $39.3M | $74.0M | $130.7M | $115.3M | $210.2M | $93.3M |
| Dívida Líquida | -$273.1M | -$340.7M | -$314.1M | -$261.4M | -$558.1M | -$674.7M | -$1.06B | -$796.9M | -$391.3M | -$356.6M |
| Capital de Giro | $250.6M | $323.5M | $284.4M | $253.8M | $552.3M | $643.5M | $1.09B | $883.1M | $529.0M | $423.8M |
Balanço (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caixa e Equivalentes | $193.4M | $155.5M | $134.7M | $106.1M |
| Ativos Totais | $925.3M | $842.1M | $758.8M | $857.2M |
| Passivos Totais | $176.9M | $170.7M | $137.8M | $129.5M |
| Patrimônio Líquido | $748.4M | $671.4M | $620.9M | $727.7M |
| Dívida Total | $98.0M | $93.3M | $80.5M | $73.4M |
Fluxo de Caixa (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Lucro Líquido | -$31.6M | -$67.5M | -$85.3M | -$99.5M | -$134.2M | -$267.9M | -$474.2M | -$481.2M | -$519.0M | -$519.0M |
| Depreciação e Amortização | $1.1M | $3.0M | $4.5M | $5.6M | $6.3M | $6.9M | $7.6M | $9.0M | $10.3M | $10.3M |
| Compensação em Ações | $6.7M | $15.3M | $17.0M | $15.1M | $19.9M | $47.0M | $91.4M | $134.1M | $154.3M | $154.3M |
| Variação Capital de Giro | $59.9M | -$16.2M | $3.2M | -$20.7M | $57.5M | -$22.9M | -$53.9M | -$52.5M | $11.9M | -$73.8M |
| Fluxo de Caixa Operacional | $36.1M | -$65.3M | -$61.3M | -$103.2M | -$49.9M | -$225.0M | -$333.3M | -$394.1M | -$348.9M | -$348.9M |
| CapEx | -$6.2M | -$10.1M | -$6.4M | -$6.8M | -$3.6M | -$12.8M | -$58.4M | -$14.0M | -$5.8M | -$5.8M |
| Aquisições | 0 | 0 | $131000 | -$32.0M | 0 | -$3.0M | -$44.7M | 0 | 0 | 0 |
| Recompra de Ações | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fluxo de Caixa Livre | $29.9M | -$75.4M | -$67.6M | -$110.0M | -$53.5M | -$237.8M | -$391.7M | -$408.1M | -$354.7M | -$354.7M |
Crescimento e Margens (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crescimento Receita (anual) | | +58.5% | +16.5% | +41.6% | +34.5% | -43.0% | +57.7% | -30.4% | +59.6% | +16.9% |
| Crescimento Lucro Líquido (anual) | | -113.5% | -26.4% | -16.6% | -34.9% | -99.6% | -77.0% | -1.5% | -7.9% | +20.5% |
| Crescimento LPA (anual) | | -106.6% | -5.3% | +1.0% | -22.4% | -57.5% | -63.0% | +12.0% | +3.1% | +27.4% |
| Variação de Ações (anual) | | +4.0% | +19.6% | +9.7% | +18.5% | +26.6% | +8.6% | +15.3% | +11.4% | +9.6% |
| Crescimento FCF (anual) | | -351.7% | +10.3% | -62.7% | +51.4% | -344.5% | -64.7% | -4.2% | +13.1% | +0.0% |
| Margem Bruta | -93.2% | -159.0% | -192.8% | -151.5% | -159.4% | 79.2% | 85.5% | 75.3% | 82.2% | 76.5% |
| Margem Operacional | -195.2% | -266.3% | -298.6% | -246.8% | -235.5% | -810.4% | -879.0% | -1420.5% | -923.1% | -651.7% |
| Margem EBITDA | -188.5% | -254.9% | -283.9% | -233.8% | -224.6% | -789.6% | -895.3% | -1301.8% | -879.0% | -586.3% |
| Margem Líquida | -192.0% | -258.6% | -280.4% | -230.9% | -231.5% | -810.5% | -909.8% | -1326.5% | -896.8% | -609.9% |
| Margem FCF | 181.7% | -288.6% | -222.2% | -255.3% | -92.2% | -719.4% | -751.5% | -1124.9% | -612.8% | -524.1% |
| Taxa Efetiva de Imposto | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Dados por Ação (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Ação | $0.87 | $-2.09 | $-1.57 | $-2.33 | $-0.96 | $-3.35 | $-5.09 | $-4.60 | $-3.59 | $-3.27 |
| Dividendo por Ação | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Ações em Circulação (Básicas) | $34.6M | $36.0M | $43.1M | $47.2M | $56.0M | $70.9M | $77.0M | $88.8M | $98.8M | $108.4M |
O que olhar em Biotech
A maioria das biotechs pequenas perde dinheiro. Analisar com P/E não faz sentido — olha caixa e pipeline.
- Cash Runway — Meses de caixa ao ritmo atual de gasto. <18 meses = risco de diluição urgente
- Cash burn anual — Ritmo a que queimam caixa operacional. Comparar com posição de caixa para projetar runway
- Dívida Total — Biotech sem receita + dívida = receita para falência
- I+D / Capitalização — Quanto investem em pipeline vs valor da empresa — indicador de intensidade de pesquisa
- Market cap / Caixa — Se cota perto do caixa, o mercado dá ~0 valor ao pipeline — oportunidade ou armadilha
Rentabilidade
| Retorno sobre patrimônio | -57.79% |
| Retorno sobre capital investido | -52.86% |
| Retorno sobre ativos | -46.66% |
| Margem bruta | -46.48% |
| Margem operacional | -711.66% |
| Margem líquida | -672.16% |
Saúde financeira
| Dívida / Patrimônio | 0.10 |
| Liquidez corrente | 6.65 |
Índices Chave (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/L | -14.41 | -10.22 | -6.89 | -7.48 | -22.67 | -31.28 | -5.66 | -5.63 | -2.22 | -2.36 |
| P/VP | 2.16 | 2.30 | 2.12 | 2.57 | 5.78 | 8.06 | 2.17 | 2.58 | 1.32 | 1.45 |
| P/V | 27.54 | 26.50 | 19.32 | 16.08 | 52.52 | 253.61 | 51.53 | 74.61 | 19.91 | 14.40 |
| Margem Bruta | -93.2% | -159.0% | -192.8% | -151.5% | -159.4% | 79.2% | 85.5% | 75.3% | 82.2% | 76.5% |
| Margem Operacional | -195.2% | -266.3% | -298.6% | -246.8% | -235.5% | -810.4% | -879.0% | -1420.5% | -923.1% | -651.7% |
| Margem Líquida | -192.0% | -258.6% | -280.4% | -230.9% | -231.5% | -810.5% | -909.8% | -1326.5% | -896.8% | -609.9% |